ConductScience.org, home

Paper28366377

Treatment of cystoid macular edema after cataract surgery.

Wielders LH and 7 others. J Cataract Refract Surg, 2017. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. Treatment of cystoid macular edema after cataract surgery. Papers, record 28366377. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28366377

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Treatment of cystoid macular edema after cataract surgery.
PubMed
Journal
J Cataract Refract Surg
PubMed
Year
2017
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Systematic Review
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
1.87
iCite
Revised in PubMed
2026-04-14
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wielders LHLaura H P
2Schouten JSJan S A G
3Aberle MRMerel R
4Lambermont VAVerena A
5van den Biggelaar FJFrank J H M
6Winkens BBjorn
7Simons RWRob W P
8Nuijts RMRudy M M A

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Inflammatory Agents, Non-SteroidalMajor topic
Cataract ExtractionMajor topic
Macular EdemaMajor topic
Diabetes Mellitus
Humans
Postoperative Complications
Risk Factors
Visual Acuity

Source PubMed

Download CSV of topics

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
42590202Association of Systemic and Ocular Comorbidities with Visual Recovery in Patients with Postoperative Corneal Oedema: A Real-World Study of Cataract Surgery Outcomes.J Clin Med2026https://conductscience.org/library/papers/42590202PubMed
42292706Bromfenac with Sodium Bisulfite Inducing Contact Dermatitis and Corneal Ring Infiltrate: A Case Report.Case Rep Ophthalmol2026https://conductscience.org/library/papers/42292706PubMed
41003131Irvine-Gass Syndrome Personalized Treatment Outcomes: A Retrospective Single-Center Cohort Study.J Pers Med2025https://conductscience.org/library/papers/41003131PubMed
40909035Cystoid Macular Edema Following Phacoemulsification and Posterior Chamber Intraocular Lens Surgery: An Aspect From the Past to the Present.Cureus2025https://conductscience.org/library/papers/40909035PubMed
37723463Real-world treatment patterns and economic burden of post-cataract macular edema.BMC Ophthalmol2023https://conductscience.org/library/papers/37723463PubMed
36607976Safety of the bag-in-the-lens implantation regarding the development of clinically significant pseudophakic cystoid macular edema: A retrospective case series study.PLoS One2023https://conductscience.org/library/papers/36607976PubMed
34967932Cataract Surgery Considerations for Diabetic Patients.Curr Diab Rep2021https://conductscience.org/library/papers/34967932PubMed
34759667Bromfenac 0.09% for the Treatment of Macular Edema Secondary to Noninfectious Uveitis.Middle East Afr J Ophthalmol2021https://conductscience.org/library/papers/34759667PubMed
33384889Safety and Comfort of an Innovative Drug Delivery Device in Healthy Subjects.Transl Vis Sci Technol2020https://conductscience.org/library/papers/33384889PubMed
33192068Efficacy of Topical Nepafenac 0.3% in the Management of Postoperative Cystoid Macular Edema.Ther Clin Risk Manag2020https://conductscience.org/library/papers/33192068PubMed
33078109Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome.Int J Ophthalmol2020https://conductscience.org/library/papers/33078109PubMed
32440977Persistence of Inflammation After Uncomplicated Cataract Surgery: A 6-Month Laser Flare Photometry Analysis.Adv Ther2020https://conductscience.org/library/papers/32440977PubMed
30614750Novel Triamcinolone Acetonide-Loaded Liposomes Topical Formulation for the Treatment of Cystoid Macular Edema After Cataract Surgery: A Pilot Study.J Ocul Pharmacol Ther2019https://conductscience.org/library/papers/30614750PubMed
29785993Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.Indian J Ophthalmol2018https://conductscience.org/library/papers/29785993PubMed
29560479Topical interferon alpha 2b in the treatment of refractory pseudophakic cystoid macular edema.Am J Ophthalmol Case Rep2018https://conductscience.org/library/papers/29560479PubMed
29459782Distinct macular thickness changes after femtosecond laser-assisted cataract surgery of age-related cataract and myopia with cataract.Sci Rep2018https://conductscience.org/library/papers/29459782PubMed
29269999Topical nepafenac for prevention of post-cataract surgery macular edema in diabetic patients: patient selection and perspectives.Clin Ophthalmol2017https://conductscience.org/library/papers/29269999PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28366377

GET https://conductscience.org/api/papers/v1/28366377/authors